Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Aimco (AIV) is in the final stages of a plan of sale and liquidation. The company has declared initial distributions and signed large asset-sale agreements, but high leverage, negative free cash flow, and a narrow window for Q2 payouts create an asymmetric near-term setup for downside. This trade targets a short-term move over the next 10 trading d…
Eagle Point Credit Management LLC sold 1,095 shares of ACRES Commercial Realty Corp’s 7.875% Series D Preferred Stock on March 30, 2026, for a weighted average of $22.12 per share, totaling $24,221. The transaction reduced but did not eliminate Eagle Point’s significant preferred and common holdings amid ACRES’s disappointing fourth-quarter 2025 ea…
Sempra Executive Vice President Justin Christopher Bird sold 1,128 shares on April 1, 2026, for $96.69 per share, generating proceeds of $109,066. The transaction occurred while the stock trades close to its 52-week high of $98.45. After the sale, Bird holds 21,631.51 shares directly and 4,722.09 shares indirectly through a 401(k) savings plan. The…
A government-appointed expert panel has concluded that ASX Ltd.'s risk management and compliance arrangements are not yet mature or embedded across its business, leaving the exchange's role in maintaining critical market infrastructure weakened. The finding follows a probe launched by regulators and has already prompted a A$150 million capital char…
Australia’s corporate regulator has concluded an independent inquiry with findings that ASX exhibited governance weaknesses, inadequate risk management and insufficient stewardship of critical market infrastructure. The panel’s final report, based on extensive interviews and document review, echoes interim conclusions and calls for transformational…
HII's Ingalls Shipbuilding division successfully launched the guided missile destroyer USS George M. Neal (DDG 131), the fourth Flight III Arleigh Burke-class destroyer built at the Pascagoula shipyard. Featuring advanced radar and combat systems, the ship moves into outfitting and system testing before sea trials, reflecting significant progress f…
Director James Aloysius Brady sold 10,834 shares of Xeris Biopharma Holdings Inc on March 30, 2026 under a Rule 10b5-1 plan for $60,035. The company recently reported a fourth-quarter 2025 earnings and revenue beat and retains analyst interest, with price targets ranging from $8 to $18 and Barclays reiterating an Overweight rating with a $9 target.
Richard D. Gebert, a director at Independence Realty Trust, INC. (NYSE: IRT), sold 500 shares on April 1, 2026 through a Form 4 filing. The transaction, executed under a pre-arranged 10b5-1(c) trading plan, totaled $7,425. The sale coincides with IRT trading near its 52-week low and follows the REIT's mixed fourth-quarter financial results and a qu…
Phillips 66 Executive Vice President and CFO Kevin J. Mitchell sold 15,629 shares of company stock on March 30, 2026, for $2.97 million and simultaneously exercised options to acquire the same number of shares. The transactions leave Mitchell with 97,376 directly held shares and a smaller indirect stake through the COP Savings Plan. The moves coinc…
Mari Steinmetz, Kohl’s Senior Executive Vice President and Chief People Officer, completed automated sales of 1,954 Kohl’s shares on March 31 and April 1, 2026, totaling about $25,383. The transactions were made under a Rule 10b5-1 trading plan adopted November 26, 2025. Around the same dates she was awarded 33,091 shares under the company’s long-t…
Gevo, Inc. President and COO Christopher Michael Ryan sold 129,797 shares across two days under a previously established 10b5-1 plan, reducing but not materially changing his direct stake. The transactions coincided with the stock trading close to its 52-week high, amid a quarter that delivered sharply higher revenue yet continued operating losses.…
Quanta Services (PWR) sits at the intersection of power, renewables, and communications infrastructure. With a market cap north of $83 billion, a $44 billion backlog, and free cash flow of roughly $1.52 billion, the company can be an effective way to play the multiyear electrification and data-center build cycle. We present a long trade with clear …
Newmont (NEM) is trading below near-term resistance after a volatile gold patch tied to geopolitical headlines. The company’s balance sheet, record free cash flow, and attractive valuation metrics argue for a tactical long. I recommend entering at the current level with a mid-term horizon and disciplined stop.
Paula Soteropoulos, a director at Dianthus Therapeutics, sold 599 shares on March 31, 2026, at $80.11 per share for $47,985 and concurrently exercised options to acquire 599 shares at $8.44 per share. The stock has since risen to $84.54 and trades close to an InvestingPro-tracked 52-week high of $88.49 after a 402% gain over the past year. The tran…
Ryan Savitz, EVP, CFO and CBO of Dianthus Therapeutics, sold $9.5 million of company stock on March 31, 2026, and exercised options to acquire additional shares the same day. The transactions occurred under a Rule 10b5-1 plan adopted in late December 2025. Separately, Dianthus completed a public offering that generated roughly $719 million in gross…
Mexico's benchmark stock index advanced on Wednesday, supported by sector gains in industrials, consumer goods and consumer staples. The S&P/BMV IPC closed 1.59% higher, with miners and select consumer names posting the strongest moves. Market breadth favored winners as gold futures jumped and crude oil prices weakened.
David Young, President of Research & Development at Processa Pharmaceuticals, purchased 1,810 shares of the company on March 31, 2026, for $2.535 per share, a $4,588 transaction. Following the purchase Young's direct holding rose to 10,562 shares, with additional indirect holdings across a trust, family entities, and an LLC. Processa, a small-cap b…
The U.S. Department of Defense has granted Boeing a $900 million indefinite-delivery/indefinite-quantity contract to provide total life cycle sustainment for the T-38C Avionics System. Work will be carried out at numerous Air Force bases and other sites, with the contract expected to run through March 31, 2036. At award, the Air Force obligated $56…
Colombia's main stock index, the COLCAP, closed lower on Wednesday, slipping 0.24% as losses in the Financials, Investment and Public Services sectors outweighed gains in select mining and utility names. Mineros SA, Grupo Cibest SA and Interconnection Electric SA ESP led advancers, while Cementos Argos Pf, Organizacion Terpel SA and Corporacion Fin…
A Processa Pharmaceuticals director purchased 2,072 shares on March 31, 2026, for $2.535 each, adding $5,252 to her direct stake as the company progresses a Phase 2 study and shows mixed recent stock performance. The transaction was disclosed in a Form 4 filing and follows recent clinical enrollment milestones.
Processa Pharmaceuticals Chief Executive Officer George K Ng purchased 2,136 shares of the company on March 31, 2026, for a total of $5,414. The transaction increases his direct and indirect holdings. Separately, the company has completed enrollment and dosing of 20 patients for an interim analysis in its Phase 2 study of NGC-Cap in advanced or met…
Brent W. Clum, Co-CEO and CFO of TXO Partners, L.P. (NASDAQ: TXO), sold 27,234 common units on April 1, 2026, at $12.38 per unit, generating proceeds of $337,156. After the transaction he holds 800,340 common units. The partnership has seen a year-to-date stock gain of 20.76% and is flagged as undervalued by InvestingPro, offering a 9.54% dividend …
Processa Pharmaceuticals Chief Financial Officer Russell Skibsted purchased 2,324 shares of the company on March 31, 2026, spending $5,891 at $2.535 per share. The trade was reported on a Form 4 and leaves Skibsted with direct ownership of those shares. The stock is trading at $2.60 with analysts setting a price target of $25, per InvestingPro data…
Russian equities closed marginally higher on Wednesday, with the MOEX Russia Index finishing up 0.01%. Gains were concentrated in the Mining, Power and Manufacturing sectors, while select large-cap energy and fertilizer names registered notable declines. Market breadth showed more advancing issues than decliners, and the Russian Volatility Index ro…
Patrick Lin, Chief Business - Strategy Officer at Processa Pharmaceuticals, acquired 1,603 shares of common stock on March 31, 2026, a purchase valued at $4,063. The transaction leaves Lin with 3,356 shares directly and 1,740 shares indirectly via the Lin Family Trust Feb 4, 2024. Separately, Processa has finished enrollment and dosing for a planne…
